She currently serves as Executive Chair and interim CEO of Nutcracker Therapeutics, a contract, research, development and manufacturing organization with a next generation RNA precision manufacturing ...

She currently serves as Executive Chair and interim CEO of Nutcracker Therapeutics, a contract, research, development and manufacturing organization with a next generation RNA precision ...

Collins, 66, currently serves as Executive Chair and Interim Chief Executive Officer of Nutcracker Therapeutics, Inc. since February 2025. Her previous roles include CEO positions at Editas Medicine ...